HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contact transscleral cyclophotocoagulation in the treatment of neovascular glaucoma: a five-year follow-up.

AbstractBACKGROUND:
The purpose of the study was to evaluate the long-term efficacy of contact transscleral cyclophotocoagulation (TSCPC) performed after panretinal photocoagulation and cryoapplication in patients with angle closure neovascular glaucoma.
MATERIAL/METHODS:
Thirty eyes of 30 patients with angle closure neovascular glaucoma were enrolled (15 women and 15 men, mean age: 55+/-21 years). Diode TSCPC was performed in all patients after panretinal photocoagulation and cryotherapy. Follow-up was 60 months.
RESULTS:
The mean pretreatment and postoperative intraocular pressures (IOPs) were 39.8+/-12 and 20.6+/-3.6 mmHg, respectively (p<0.00001). The mean number of treatment sessions was 2.4+/-1.5 (range: 1+/-7), with 18 eyes receiving only one treatment. There was a decrease in visual acuity in 3, hyphema in 4, uveitis in 2, cataract in 3, and phthisis in 1 eye.
CONCLUSIONS:
1. TSCPC provides long-term control of IOP in patients with angle closure neovascular glaucoma. 2. Laser panretinal photocoagulation and cryoapplication should be considered before TSCPC. 3. TSCPC is associated with numerous complications, hyphema being the most frequent.
AuthorsRafał Leszczyński, Robert Domański, Maria Formińska-Kapuścik, Ewa Mrukwa-Kominek, Iwona Rokita-Wala
JournalMedical science monitor : international medical journal of experimental and clinical research (Med Sci Monit) Vol. 15 Issue 3 Pg. BR84-7 (Mar 2009) ISSN: 1643-3750 [Electronic] United States
PMID19247237 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Follow-Up Studies
  • Glaucoma, Neovascular (diagnostic imaging, physiopathology, surgery)
  • Humans
  • Intraocular Pressure (physiology)
  • Light Coagulation (methods)
  • Male
  • Middle Aged
  • Sclera (diagnostic imaging, pathology, surgery)
  • Time Factors
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: